
Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib
Keywords: سیتوکین; Gefitinib; EGFR; MIP-1β; Cytokine; Lung cancer; Skin toxicity;